These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Thanatophoric dysplasia type II: new entity?
    Author: Weber M, Johannissón R, Carstens C, Pauschert R, Niethard FU.
    Journal: J Pediatr Orthop B; 1998 Jan; 7(1):10-22. PubMed ID: 9481651.
    Abstract:
    There is some question about whether the two forms of thanatophoric dysplasia (TD), Type II with and Type I without cloverleaf skull, belong to the same entity. Thus, we investigated one 6-day-old TD with cloverleaf skull using examination of the external phenotype, radiology, autopsy, skeleton preparation, large section histology, detailed section histology, and ultrastructure. The loss of the three-phase contours-characteristics for Type I (54)--in certain metaphyses, the absence of the perichondral spurs to some extent, and their substitution by a structure similar to the perichondral "ring of Lacroix" have a suggested origin in normal cartilage-bone tissue. The same mechanism is postulated (a) for the appearance of less bent or normally shaped tubular bones compared with TD Type I, and their corresponding increased mechanical stability, and (b) for the less amount of platyspondyly in Type II than in Type I. We suggest that the malformation of the cloverleaf skull has its origin in the promontory growth of the relatively normal cartilage-bone tissues at the skull base resulting in an early synostosis and a consecutive fusion of the cranial sutures. The ultrastructural analysis of chondrocytes demonstrates the significant contribution of electron microscopy for TD studies. We suggest that pathologically altered light chondrocytes accounts for plump cross-striated collagen fibrils, the reduced cellular proliferation, and the impaired formation of columnar and hypertrophic zones. It is clear that normal cartilage-bone tissue distributed among "thanatophoric" tissue is the reason for the differences between Type I and Type II. Hypotheses are presented that explain this tissue mosaicism. Thus, TD Type I and TD Type II do not represent two different entities but the same entity with varying features due to mutational events occurring at different times.
    [Abstract] [Full Text] [Related] [New Search]